Software EULA

DR-IT commercial software end user licence agreement

Effective date: 1 November 2026
Version: 1.0

1. Parties and acceptance

This End User Licence Agreement (“Agreement”) is between DR-IT Informatikai Korlátolt Felelősségű Társaság, short name DR-IT Kft., a company organised under the laws of Hungary, company registration number 13-09-220015, VAT number 13101431-2-13, with registered office at 2038 Sóskút, Patak utca 1/A, Hungary (“DR-IT”), and the individual or legal entity identified in the applicable order, licence certificate, or checkout confirmation (“Licensee”, “you”).

By downloading, installing, copying, activating, or using a Product, you accept this Agreement. If you accept on behalf of an organisation, you represent that you have authority to bind it. If you do not agree, do not use the Product.

An order, licence certificate, invoice, or checkout confirmation (“Order”) identifies the Product, licence tier, named-developer limit, commercial-distribution permissions, quantity, support/update term, and any agreed special terms. In a conflict, the Order controls the commercial scope only; this Agreement controls unless a written agreement signed by authorised representatives expressly states otherwise.

2. Definitions

  • “Product” means the commercial DR-IT component named in the Order: DRIT.Spreadsheet, DRIT.Document, DRIT.Presentation, DRIT.Pdf, or the DR-IT Office Bundle, including its associated documentation and any update supplied under an active Updates & Support Plan.
  • “Named Developer” means a natural person who writes, tests, builds, maintains, or releases software using the Product. Production servers, CI/CD agents, end users, and passive users of an application are not Named Developers.
  • “Application” means Licensee’s software that provides substantial independent functionality beyond the Product.
  • “Production Service” means a separately branded or separately billable customer-facing hosted application or service operated by Licensee. Its servers, regions, tenants, and non-production environments count as one service.
  • “Commercial Offering” means a separately branded software product that Licensee sells, licenses, or supplies to customers. Updates, editions, platforms, customer installations, and versions of the same offering count as one.
  • “Customer Deployment” means one legal entity receiving access to a public developer API or SDK that materially exposes Product-backed functionality. Users, workspaces, and servers within that entity do not multiply the count.
  • “Public Developer API/SDK” means an interface intended for another developer to programmatically invoke Product-backed document functionality. A normal end user uploading/downloading a document through an Application does not, by itself, create a Public Developer API/SDK.
  • “Updates & Support Plan” means the time-limited plan described in section 8.

3. Licence grant

Subject to payment (where applicable) and compliance with this Agreement, DR-IT grants Licensee a limited, non-exclusive, non-transferable, non-sublicensable, worldwide licence to install and use the Product solely as permitted by its Order and this Agreement.

The licence is perpetual for the Product version(s) released during Licensee’s active Updates & Support Plan. “Perpetual” means the right to continue using those eligible versions; it does not mean a right to future releases, private support, new platforms, or new features after the plan ends.

Licensee may make reasonable copies for backup, development, test, staging, and production use within its purchased entitlement. The Product may be used in unlimited internal/private Applications of the purchasing legal entity unless the Order states otherwise.

4. Licence tiers and permissions

4.1 Paid base commercial licence

A paid base commercial licence permits use by up to the Named Developer quantity in the Order for internal/private Applications. It does not, by itself, permit customer-facing SaaS, commercial distribution of the Product runtime to third parties, or a Public Developer API/SDK.

Licensee may replace a Named Developer only if the former person permanently stops using the Product. Licensee must not rotate a single seat among concurrent or intermittent users to avoid the purchased developer quantity.

4.2 SaaS permission

If the Order includes a SaaS permission, Licensee may deploy the Product within up to the number of Production Services stated in the Order. SaaS permission permits Licensee’s customer-facing service; it does not permit a Public Developer API/SDK unless the Order separately includes SDK/API permission, and it does not permit resale of the Product as a stand-alone component.

4.3 OEM permission

If the Order includes an OEM permission, Licensee may embed and distribute the Product runtime solely as an inseparable part of up to the number of Commercial Offerings in the Order. Licensee must ensure that each Application supplies substantial independent functionality and does not expose, market, transfer, or enable extraction/reuse of the Product as a stand-alone library.

4.4 SDK/API permission

If the Order includes SDK/API permission, Licensee may expose Product-backed functionality through a Public Developer API/SDK to up to the number of Customer Deployments stated in the Order. This does not grant any right to give customers the Product itself, Product source code, a DR-IT licence key, or development/compilation access to the Product except as expressly agreed in writing.

4.5 Free, personal, academic, and evaluation modes

If DR-IT supplies a Product under a free, personal, academic, preview, or evaluation licence, the additional terms displayed with that licence apply. The published licence page and technical limits must be product-specific.

  • Evaluation: all features for 30 days solely to evaluate the Product; no production use or redistribution. Any extension must be in writing or recorded in an issued evaluation licence.
  • Free commercial sample: limited functionality as stated for the relevant Product; it may be used only within those technical limits and must not bypass limits or licence checks.
  • Personal: all features for an individual’s personal, hobby, volunteer, non-revenue use; no work for an employer/client, commercial activity, or redistribution unless expressly stated.
  • Academic: all features for verified academic instruction, non-commercial research, and internal institutional use; the scope of any compiled-application redistribution must be stated in the issued academic licence.

An Order or licence certificate may impose a more limited scope. Licensee must not combine licences to circumvent a quantity, commercial-permission, or technical limit.

5. Restrictions

Except to the extent mandatory law prohibits the restriction, Licensee must not:

  1. sell, rent, lease, sublicense, assign, transfer, publish, distribute, or make the Product available as a stand-alone product or reusable component;
  2. provide the Product, its licence key, or Product-derived development functionality to another developer except under an Order expressly authorising SDK/API permission;
  3. reverse engineer, decompile, disassemble, or attempt to derive source code from the Product, except to the limited extent permitted by mandatory law;
  4. remove or alter proprietary notices, licence controls, or technical restrictions;
  5. use the Product beyond the Named Developer, Production Service, Commercial Offering, Customer Deployment, or other quantity in the Order;
  6. use the Product to create, distribute, or operate a stand-alone library, tool, or service that makes the Product available for reuse outside Licensee’s permitted Application; or
  7. use the Product in violation of export controls, sanctions, or other applicable law.

These restrictions do not limit Licensee’s rights in DR-IT components expressly distributed under an open-source licence; those components are governed by their stated licence.

6. Intellectual property and feedback

The Product is licensed, not sold. DR-IT and its licensors retain all intellectual-property and other rights in the Product, documentation, and copies. Licensee retains rights in its Applications and data, excluding the Product and DR-IT materials.

If Licensee provides feedback, it grants DR-IT a non-exclusive, worldwide, perpetual, irrevocable, royalty-free right to use that feedback to improve its products and services, without identifying Licensee or disclosing Licensee confidential information. Do not submit confidential information in feedback unless separately agreed.

7. Licence keys, data, and audits

Licence keys are confidential and may be used only within Licensee’s permitted scope. Licensee must take reasonable measures to prevent disclosure, including avoiding publication in source repositories, client applications, or public configuration.

The Product must not transmit document contents, customer data, or personal data to DR-IT unless the Product documentation and Privacy Notice expressly say so and a lawful basis applies. DR-IT’s current operating baseline is no Product telemetry, crash reporting, remote licence activation, or document-content/metadata upload. If this changes, DR-IT will update the applicable documentation and privacy information before enabling the change.

On reasonable written notice, no more than once in a 12-month period, DR-IT may request records reasonably necessary to verify compliance with the purchased scope. Any verification must protect Licensee confidentiality, avoid access to unrelated systems or document content, and be conducted by DR-IT or an independent auditor bound by confidentiality. If a material under-licensing is confirmed, Licensee must promptly purchase the missing entitlement and reasonable verification costs only where permitted by law and proportionate.

8. Updates and support

The initial Order includes 12 months of the Updates & Support Plan unless it states otherwise. During the active plan, DR-IT may provide updates, bug fixes, documentation changes, and standard technical support. Updates are part of the Product and governed by this Agreement.

DR-IT will use reasonable efforts to respond to standard paid-support requests within two business days. This is a service target, not a guaranteed resolution time or service-level agreement. DR-IT does not warrant that every issue will be fixed or that a particular feature will be developed.

DR-IT may need a customer file to investigate and resolve a support case. DR-IT will request any such file only through a secure, case-specific support-upload/transfer feature once that feature is made available and documented. Use of that feature is optional and must be initiated by Licensee. Licensee may submit only the minimum material needed to investigate the case and only data it is authorised to provide. Credentials, payment-card data and special-category personal data must not be submitted unless DR-IT expressly requests them through that secure feature and they are necessary. DR-IT will process submitted files only for the documented support case, restrict access to authorised personnel, and delete/return them under the applicable retention terms. Where DR-IT processes a business customer’s personal data in those files solely on that customer’s documented instructions, the applicable DPA governs that processing.

Licensee may renew the Updates & Support Plan at the price and timing displayed at purchase or renewal. An expired plan does not terminate the perpetual licence for previously eligible versions. Community resources may remain available, but private support and future releases require an active plan unless DR-IT states otherwise.

9. Warranties, exclusions, and consumer rights

DR-IT warrants that it has the right to grant the licence in this Agreement. Subject to mandatory law, the Product is otherwise supplied “as is” and “as available”. DR-IT does not warrant uninterrupted, error-free operation; compatibility with every third-party system; fitness for Licensee’s particular purpose; or that all defects will be corrected.

Nothing in this Agreement excludes or limits rights that cannot lawfully be excluded, including mandatory consumer rights. If Licensee is a consumer, mandatory laws of Licensee’s habitual residence may apply in addition to this Agreement. The consumer-information and withdrawal requirements in section 12 must be completed before consumer sales begin.

10. Limitation of liability

To the maximum extent permitted by law, neither party is liable for indirect, incidental, special, punitive, or consequential loss, or loss of profit, revenue, goodwill, data, or business opportunity arising from this Agreement.

For business Licensees, DR-IT’s aggregate liability arising from or relating to the affected Product or this Agreement must not exceed the amount paid for that Product in the 12 months before the event giving rise to liability. For a one-time perpetual licence without a recurring payment in that period, the cap is the amount actually paid for that licence. This section does not limit liability that cannot lawfully be limited, including liability for intentional misconduct, fraud, death/personal injury where applicable, or mandatory consumer remedies.

11. Termination

This Agreement continues for the perpetual licence term unless terminated for material breach. DR-IT may terminate after written notice if Licensee materially breaches this Agreement and does not cure the breach within 30 days where cure is possible. On termination, Licensee must stop using and distributing the Product and destroy or return copies on request, except where mandatory law or a written settlement provides otherwise. Sections intended by their nature to survive will survive.

12. Consumer sales

DR-IT may sell Products to both businesses and consumers. A consumer is a natural person acting outside their trade, business, craft, or profession. Mandatory consumer protections apply to consumer purchases and prevail over any conflicting provision of this Agreement.

Before a consumer is bound, checkout must provide the trader’s identity/contact details, total price/taxes, Product functionality and interoperability, update/support information, contract duration, and withdrawal information. The consumer will receive a durable contract confirmation containing the applicable Order and Agreement.

For immediate supply of downloadable digital content, use an unchecked, separate statement such as: “I expressly request immediate supply of the digital content and acknowledge that, once supply begins, I lose my statutory right of withdrawal.” Record the affirmative action and include it in the contract confirmation. Do not use this statement for a consumer unless counsel confirms the flow and the actual supply model meet the applicable legal conditions.

Consumer rights relating to withdrawal, conformity, remedies, and necessary updates are not limited by the “perpetual” licence label, the refund policy, or any limitation/exclusion in this Agreement. DR-IT’s 30-day commercial refund promise is additional to, not a substitute for, mandatory rights.

13. Governing law, notices, and general terms

This Agreement is governed by Hungarian law, excluding conflict-of-law rules, except that a consumer retains the protection of mandatory provisions of the law of the consumer’s habitual residence. Courts with mandatory jurisdiction remain competent. The parties should first try in good faith to resolve a dispute through info@dritsoftware.com.

Notices to DR-IT must be sent to info@dritsoftware.com and, where a physical notice is required, to DR-IT’s registered office at 2038 Sóskút, Patak utca 1/A, Hungary. DR-IT may give operational notices through the account, email address in the Order, or Website where legally permitted.

This Agreement and the Order are the entire agreement on the Product, replacing prior discussions on the same subject. A waiver must be written. If a provision is unenforceable, it will be modified to the minimum extent necessary and the remainder will continue. Licensee may not assign this Agreement without DR-IT’s written consent, except to a successor in a merger or sale of substantially all relevant assets that agrees in writing to be bound; DR-IT may assign to an affiliate or successor on notice where permitted by law.